Latest Articles
-
Can In Vivo CRISPR Gene Editing Lower the Cost of Cancer Immunotherapy
Researchers are moving CAR-T cell therapy from the lab to the patient's body using CRISPR, potentially making life-saving cancer treatment cheaper and faster.
science -
Is the massive surge in AI infrastructure spending sustainable for the global tech market
Explore the implications of a $650 billion investment in data centers, its impact on hardware prices, and the risks of prioritizing AI over consumer tech.
technology -
Will the OpenAI military contract damage its standing with enterprise and consumer users
Analyzing the fallout of OpenAI's pivot toward military AI applications and the resulting impact on its user trust and market dominance.
technology -
Why Did Bluesky Wait Eleven Months to Disclose Its Hundred Million Dollar Funding Round
Analyze the implications of Bluesky's delayed $100M Series B funding announcement and what the leadership transition means for the decentralized platform's future.
technology